CLINICAL PHARMACY questions and answers

CLINICAL PHARMACY Philippine Association of Colleges of Pharmacy CLINICAL PHARMACY 1. It refers to the responsible provision of drug therapy to achieve definite outcomes that are intended to improve a patient’s quality of life A. Professional-patient’s relationship B. Therapeutic drug monitoring C. Drug therapy assessment D. Pharmaceutical care E. Formal documentation 2. It involves measuring direct and indirect costs attributable to a specific disease A. Cost-of-Illness Evaluation B. Cost-Effectiveness Analysis C. Cost-Minimization Analysis D. Cost-Utility Analysis E. Cost-Benefit Analysis 3. The method that allows for the identification, measurement, and comparison of the benefits and costs of a program or treatment alternative A. Cost-of-Illness Evaluation B. Cost-Effectiveness Analysis C. Cost-Minimization Analysis D. Cost-Utility Analysis E. Cost-Benefit Analysis 4. The method that involves the determination of the least costly alternative when comparing two or more treatment alternatives A. Cost-of-Illness Evaluation B. Cost-Effectiveness Analysis C. Cost-Minimization Analysis D. Cost-Utility Analysis E. Cost-Benefit Analysis 5. The method that integrates the patient preferences and health-related quality of life A. Cost-of-Illness Evaluation B. Cost-Effectiveness Analysis C. Cost-Minimization Analysis D. Cost-Utility Analysis E. Cost-Benefit Analysis 6. A way of summarizing the health benefits and resources used by competing health care programs so that policy makers can choose among them A. Cost-of-Illness Evaluation B. Cost-Effectiveness Analysis C. Cost-Minimization Analysis D. Cost-Utility Analysis E. Cost-Benefit Analysis 7. It refers to the value assigned to duration of life as modified by impairments, functional states, perceptions and social opportunities that are influenced by disease, injury, treatment or policy A. Optimum health B. Quality of life C. Health outcomes D. Responsiveness E. Wellness of being 8. A study design in which neither the study subject nor the study staff is aware of which group or intervention the subjects has been assigned A. Randomized control trial B. Crossover study C. Cohort study D. Blinded study E. Cross-sectional study 9. A retrospective comparison of causal factors or exposures in a group of persons with disease and those of persons without the disease A. Randomized control trial B. Case control study C. Cohort study D. meta-analysis E. open-label trial 10. A retrospective or prospective follow-up study of exposed and non-exposed defined groups in which a variable of interest is measured A. Cross-sectional study B. Case control study C. Cross over study D. Cohort study E. open label trial